Lenalidomide Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026

Lenalidomide Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026

  • Transparency Market Research
  • Ongoing
  • Healthcare

Report Description


Lenalidomide is an equivalent to thalidomide, developed to reduce dose-limiting side effects of thalidomide such as constipation, sedation, neuropathy, and thromboembolism. Lenalidomide is used to manage anemia in individuals who have a certain form of myelodysplastic syndrome. Lenalidomide and low-dose of dexamethasone are used to treat patients with multiple myeloma. It is also utilized to treat the mantle cell lymphoma patients. Lenalidomide is primarily used for the treatment for multiple myeloma. The treatment for multiple myeloma has changed considerably in the last few years; however, the disease remains incurable. Multiple myeloma is a cancer that starts in bone marrow. In this type of cancer, normal antibody producing cells transform into cancerous myeloma cells that produces large number of abnormal immunoglobulin or antibodies known as monoclonal proteins.

Increase in prevalence of multiple myeloma and rise in demand for better treatment options are expected to boost the lenalidomide market during the forecast period. According to the American Cancer Society, in 2016, around 230,000 people were diagnosed with multiple myeloma globally. Nearly, 30,000 people were diagnosed with the disease in the U.S. Moreover, around 77,000 people were suffering from multiple myeloma in Europe. 

The global lenalidomide market can be segmented based on application, end-user, and region. In terms of application, the lenalidomide market can categorized into multiple myeloma, myelodysplastic syndromes, and others. Multiple myeloma is a B-cell malignancy of the plasma cell. It is the second most common hematological malignancy. Lenalidomide was primarily projected as a management for multiple myeloma, for that thalidomide is a recognized therapeutic treatment. It has proven effectiveness in hematological disorders recognized as myelodysplastic syndromes. Beside with numerous other drugs developed in past few years, it has considerably improved total survival in myeloma (which previously carried a poor prognosis), while toxicity remains an issue for users. Based on end-user, the global lenalidomide market can be segmented into hospitals, cancer treatment centers, and research institutes.

The global lenalidomide market can be divided into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The lenalidomide market in North America can be further segmented into the U.S. and Canada. The market in Europe can be segmented into the U.K., Germany, France, Italy, Spain, and Rest of Europe. The lenalidomide market in Asia pacific can be categorized into Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific. The market in Latin America can be classified into Mexico, Brazil, and Rest of Latin America. The lenalidomide market in Middle East & Africa can be segregated into Saudi Arabia, South Africa, Israel, and Rest of Middle East and Africa. Europe is expected to dominate the global Lenalidomide market during the forecast period due to high prevalence of multiple myeloma in the region. Moreover, rise in patient awareness is expected to boost the market during the forecast period.

Some of the key players operating in the lenalidomide market are Celegene, Ablynx, Celegene, Natco Pharma, Celltrion, LEO Pharma, Dexa Medica,Toyama Chemical, Actiza, Tsumura, HanAll Biopharma, Dr. Reddy’s.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis. 

Have query on this report?

Make an Enquiry

Success Stories

Our Clients